| 1 |
Lyle AN, Taylor WR. The pathophysiological basis of vascular disease[J]. Lab Invest, 2019, 99(3):284-289.
|
| 2 |
Lacolley P, Regnault V, Segers P, et al. Vascular smooth muscle cells and arterial stiffening:Relevance in dev elopment, aging, and disease[J]. Physiol Rev, 2017, 97(4):1555-1617.
|
| 3 |
Harper RL, Ferrante EA, Boehm M. Development of vascular disease models to explore disease causation and pathomechanisms of rare vascular diseases[J]. Semin Immunopathol, 2022, 44(3):259-268.
|
| 4 |
Fernandes DC, Reis RL, Oliveira JM. Advances in 3D neural, vascular and neurovascular models for drug testing and regenerative medicine[J]. Drug Discov Today, 2021, 26(3):754-768.
|
| 5 |
Datta P, Ayan B, Ozbolat IT. Bioprinting for vascular and vascularized tissue biofabrication[J]. Acta Biomater, 2017, 51:1-20.
|
| 6 |
Biswas PK, Park J. Applications, challenges, and prospects of induced pluripotent stem cells for vascular disease[J]. Mol Cells, 2024, 47(7):100077.
|
| 7 |
Maguire EM, Xiao Q, Xu Q. Differentiation and application of induced pluripotent stem cell-deriv ed vascular smooth muscle cells[J]. Arterioscler Thromb Vasc Biol, 2017, 37(11):2026-2037.
|
| 8 |
Ayoubi S, Sheikh SP, Eskildsen TV. Human induced pluripotent stem cell-derived vascular smooth muscle cel ls:differentiation and therapeutic potential[J]. Cardiovasc Res, 2017, 113(11):1282-1293.
|
| 9 |
Shen M, Quertermous T, Fischbein MP, et al. Generation of vascular smooth muscle cells from induced pluripotent st em cells:Methods, applications, and considerations[J]. Circ Res, 2021, 128(5):670-686.
|
| 10 |
Vila Cuenca M, Cochrane A, Van Den Hil FE, et al. Engineered 3D vessel-on-chip using hiPSC-derived endothelial-and vascular smooth muscle cells[J]. Stem Cell Reports, 2021, 16(9):2159-2168.
|
| 11 |
LIM GB. Vascular disease:treatment of ischaemic vascular disease with 3D-prin ted vessels[J]. Nat Rev Cardiol, 2017, 14(8):442-443.
|
| 12 |
Xu C, He S, Zhu Y, et al. Vascular organoid generation from human-induced pluripotent stem cells[J]. J Vis Exp, 2024, 214:10.
|
| 13 |
Cooper ID. Bibliometrics basics[J]. J Med Libr Assoc, 2015, 103(4): 217-218.
|
| 14 |
Roldan-Valadez E, Salazar-Ruiz SY, Ibarra-Contreras R, et al. Current concepts on bibliometrics:a brief review about impact factor, Eigenfactor score, CiteScore, SCImago Journal Rank, Source-Normalised Impact per Paper, H-index, and alternative metrics[J]. Ir J Med Sci, 2019, 188(3):939-951.
|
| 15 |
Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization:The STROBE-MR statement[J]. JAMA, 2021, 326(16):1614-1621.
|
| 16 |
Pan D, Wang J, Wang H, et al. Mapping the blueprint of artificial blood vessels research:a bibliometric analysis[J]. Int J Surg, 2025, 111(1):1014-1031.
|
| 17 |
Bringmann LF, Elmer T, Epskamp S, et al. What do centrality measures measure in psychological networks?[J]. J Abnorm Psychol, 2019, 128(8):892-903.
|
| 18 |
Xiang N, Wang Q, You M. Estimation and update of betweenness centrality with progressive algorithm and shortest paths approximation[J]. Sci Rep, 2023, 13(1):17110.
|
| 19 |
Tao S, Tang X, Yu L, et al. Prognosis of coronary heart disease after percutaneous coronary intervention:a bibliometric analysis over the period 2004-2022[J]. Eur J Med Res, 2023, 28(1):311.
|
| 20 |
Wang L, Xu Y, Qin T, et al. Global trends in the research and development of medical/pharmaceutical wastewater treatment over the half-century[J]. Chemosphere, 2023, 331:138775.
|
| 21 |
Deng H, Huang Z, Li Z, et al. Systematic bibliometric and visualized analysis of research hotspots and trends in attention-deficit hyperactivity disorder neuroimaging[J]. Front Neurosci, 2023, 17: 1098526.
|
| 22 |
Roh JD, Sawh-Martinez R, Brennan MP, et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling[J]. Proc Natl Acad Sci U S A, 2010, 107(10):4669-4674.
|
| 23 |
Camp JG, Sekine K, Gerber T, et al. Multilineage communication regulates human liver bud development from pluripotency[J]. Nature, 2017, 546(7659):533-538.
|
| 24 |
Vatine GD, Barrile R, Workman MJ, et al. Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications[J]. Cell Stem Cell, 2019, 24(6):995-1005.e6.
|
| 25 |
Pan Z, Yao Q, Kong W, et al. Generation of iPSC-derived human venous endothelial cells for the mode ling of vascular malformations and drug discovery[J]. Cell Stem Cell, 2025, 32(2):227-245.e9.
|
| 26 |
Gupta K, Perkerson RB, 3rd, Parsons TM, et al. Secretome from iPSC-derived MSCs exerts proangiogenic and immunosuppre ssive effects to alleviate radiation-induced vascular endothelial cell damage[J]. Stem Cell Res Ther, 2024, 15(1):230.
|
| 27 |
Uslu Ö, Herold J, Kanse SM. VEGF-A-Cleavage by FSAP and inhibition of neo-vascularization[J]. Cells, 2019, 8(11):1396.
|
| 28 |
Zhilan T, Zengyu Z, Pengpeng J, et al. Salidroside promotes pro-angiogenesis and repair of blood brain barrie r via Notch/ITGB1 signal path in CSVD Model[J]. J Adv Res, 2025, 68:429-444.
|
| 29 |
Mao C, Ma Z, Jia Y, et al. Nidogen-2 maintains the contractile phenotype of vascular smooth muscle cells and prevents neointima formation via bridging Jagged1-Notch3 signaling[J]. Circulation, 2021, 144(15):1244-1261.
|
| 30 |
Foulquier S, Daskalopoulos EP, Lluri G, et al. WNT signaling in cardiac and vascular disease[J]. Pharmacol Rev, 2018, 70(1):68-141.
|
| 31 |
Abutaleb NO, Atchison L, Choi L, et al. Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engi neered blood vessel model of Hutchinson-Gilford Progeria Syndrome[J]. Sci Rep, 2023, 13(1):5032.
|
| 32 |
Levy D, Abadchi SN, Shababi N, et al. Induced pluripotent stem cell-derived extracellular vesicles promote wound repair in a diabetic mouse model via an anti-inflammatory immunom odulatory mechanism[J]. Adv Healthc Mater, 2023, 12(26):e2300879.
|
| 33 |
Hua Q, Zhang Y, Li H, et al. Human umbilical cord blood-derived MSCs trans-differentiate into endom etrial cells and regulate Th17/Treg balance through NF-κB signaling in rabbit intrauterine adhesions endometrium[J]. Stem Cell Res Ther, 2022, 13(1):301.
|
| 34 |
Zhou Y, Singh AK, Hoyt RF Jr, et al. Regulatory T cells enhance mesenchymal stem cell survival and prolifer ation following autologous cotransplantation in ischemic myocardium[J]. J Thorac Cardiovasc Surg, 2014, 148(3):1131-1137.
|
| 35 |
Guerrero J, Dasen B, Frismantiene A, et al. T-cadherin expressing cells in the stromal vascular fraction of human adipose tissue: role in osteogenesis and angiogenesis[J]. Stem Cells Transl Med, 2022, 11(2):213-229.
|
| 36 |
Pinton L, Khedr M, Lionello VM, et al. 3D human induced pluripotent stem cell-derived bioengineered skeletal muscles for tissue, disease and therapy modeling[J]. Nat Protoc, 2023, 18(4):1337-1376.
|
| 37 |
Duan K, Dash BC, Sasson DC, et al. Human ipsc-derived vascular smooth muscle cells in a fibronectin funct ionalized collagen hydrogel augment endothelial cell morphogenesis[J]. Bioengineering(Basel), 2021, 8(12):223.
|
| 38 |
Rosowski S, Remmert C, Marder M, et al. Single-cell characterization of neovascularization using hiPSC-derived endothelial cells in a 3D microenvironment[J]. Stem Cell Reports, 2023, 18(10):1972-1986.
|
| 39 |
Chan XY, Black R, Dickerman K, et al. Three-dimensional vascular network assembly from diabetic patient-deri ved induced pluripotent stem cells[J]. Arterioscler Thromb Vasc Biol, 2015, 35(12):2677-2685.
|